Latest News about Biotech and Pharmaceuticals
Recent news which mentions Biotech and Pharmaceuticals
From pills to new uses, here's what Eli Lilly’s top scientist sees as the future of weight loss drugs
February 20, 2025
From CNBC.com News
Healthy Returns: Ozempic helps curb alcohol use in new study — and doctors are concerned about telehealth GLP-1s
February 19, 2025
From CNBC.com News
UnitedHealthcare is offering buyouts to employees in benefits unit, could pursue layoffs, sources say
February 19, 2025
From CNBC.com News
Moderna beats on revenue but loses more than expected as it scales down manufacturing
February 14, 2025
From CNBC.com News
CVS shares are up 45% this year — here's why it may be starting to turn its business around
February 13, 2025
From CNBC.com News
U.S. investors, Big Pharma race to find new medicines in China
February 13, 2025
From CNBC.com News
Healthy Returns: What to know about Trump's NIH funding cuts
February 12, 2025
From CNBC.com News
CVS CEO defends pharmacy middlemen, accuses drugmakers of 'monopolistic' practices
February 12, 2025
From CNBC.com News
Biogen beats estimates on cost cuts and new drugs like Leqembi, but profit outlook falls short
February 12, 2025
From CNBC.com News
From CNBC.com News
Trump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma
February 10, 2025
From CNBC.com News
Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected
February 06, 2025
From CNBC.com News
Eli Lilly posts mixed quarter even as demand for weight loss, diabetes drugs soars
February 06, 2025
From CNBC.com News
From CNBC.com News
Novo Nordisk CEO says he's confident about Wegovy supply, next-generation weight loss drugs
February 05, 2025
From CNBC.com News
From CNBC.com News
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.